Skip to main content

Table 1 The clinicopathological data of clinical tumor tissue samples

From: LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway

Group Sample number HER2 PR ER Age of patients Pathological grading
TNBC HMU31500600J07 (−) (−) (−) 51 T1N0M0 I
HMU31500574J07 (−) (−) (−) 73 T1N0M0 I
HMU31500519J07 (−) (−) (−) 64 T1N0M0 I
HMU31500310J07 (−) (−) (−) 61 T1N0M0 I
HMU31500306J07 (−) (−) (−) 61 T1N0M0 I
HMU31500294J07 (−) (−) (−) 52 T1N0M0 I
HMU31500268J07 (−) (−) (−) 61 T1N0M0 I
HMU31500492J07 (−) (−) (−) 77 T2N0M0 IIA
HMU31500473J07 (−) (−) (−) 61 T2N0M0 IIA
HMU31500376J07 (−) (−) (−) 40 T2N0M0 IIA
HMU31500350J07 (−) (−) (−) 45 T2N0M0 IIA
HMU31500563J07 (−) (−) (−) 52 T2N0M0 IIA
HMU31500552J07 (−) (−) (−) 64 T2N0M0 IIA
HMU31500529J07 (−) (−) (−) 65 T2N0M0 IIA
HMU31500171J07 (−) (−) (−) 63 T2N1M0 IIB
HMU31500193J07 (−) (−) (−) 56 T2N1M0 IIB
HMU31500370J07 (−) (−) (−) 65 T2N1M0 IIB
HMU31500213J07 (−) (−) (−) 43 T2N1M0 IIB
HMU31500338J07 (−) (−) (−) 49 T2N1M0 IIB
HMU31500150J07 (−) (−) (−) 51 T2N1M0 IIB
Non-TNBC HMU31500700J07 (3+) (−) (−) 56 T1N0M0 I
HMU31500698J07 (3+) (−) (−) 61 T1N1M0 IIA
HMU31500636J07 (3+) (−) (−) 51 T1N0M0 I
HMU31500710J07 (3+) (−) (−) 49 T1N0M0 I
HMU31500731J07 (3+) (−) (−) 53 T1N1M0 IIA
HMU31500688J07 (2+) (+) (+) 70 T1N0M0 I
HMU31500684J07 (2+) (+) (+) 58 T1N0M0 I
HMU31500666J07 (+) (+) (+) 66 T1N0M0 I
HMU31500697J07 (+) (+) (+) 62 T1N1M0 IIA
HMU31500680J07 (2+) (+) (+) 50 T1N1M0 IIA
HMU31500702J07 (−) (+) (+) 43 T2N1M0 IIB
HMU31500687J07 (2+) (+) (+) 52 T2N1M0 IIB
HMU31500631J07 (2+) (+) (+) 50 T2N1M0 IIB
HMU31500627J07 (−) (+) (+) 48 T2N1M0 IIB
HMU31500732J07 (2+) (+) (+) 57 T2N1M0 IIB
HMU31500755J07 (3+) (+) (+) 64 T2N1M0 IIB
HMU31500787J07 (3+) (+) (+) 53 T1N1M0 IIA
HMU31500884J07 (−) (+) (+) 44 T1N1M0 IIA
HMU31500829J07 (+) (+) (+) 52 T1N1M0 IIA
HMU31500817J07 (2+) (+) (+) 65 T1N1M0 IIA